Talabostat Mesylate
BXCL701-001
Phase 1 small_molecule terminated
Quick answer
Talabostat Mesylate for Cancer of Pancreas is a Phase 1 program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioXcel Therapeutics
- Indication
- Cancer of Pancreas
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated